/Companies

Phinomics

11 employees on LinkedIn · 1 known investors

Find your way into Phinomics

Sign up to see every warm intro you have to Phinomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Phinomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.

Founders & leadership

MSMassa Shoura
Massa ShouraFounder, CEO, CSO
SLStephen Levene
Stephen LeveneFounder, CTOStephen Levene holds a B.A. in Chemistry from Columbia University and a Ph.D. in Chemistry from Yale University, where his doctoral research focused on DNA bending and cyclization. He conducted postdoctoral research at UC San Diego on gel electrophoresis mechanisms and served as a Staff Scientist at Lawrence Berkeley National Laboratory's Human Genome Center, studying DNA topology, supercoiled DNA, and extrachromosomal circular DNA before founding Phinomics.

Investors · 1

Frequently asked questions

What does Phinomics do?
Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.
Who founded Phinomics?
Phinomics was founded by Massa Shoura, Stephen Levene.
Who are Phinomics's investors?
Phinomics's investors include Silicon Catalyst.